Pfizer Fights 'Do-Over' Of Plaintiff Experts In Zoloft MDL
Pfizer Inc. on Tuesday fought what it called the plaintiffs' bid for a "do-over" on a Pennsylvania federal court's Daubert rulings in multidistrict litigation over its antidepressant Zoloft's alleged risk of...To view the full article, register now.
Already a subscriber? Click here to view full article